Covaxin Got Approval For Phase-Iii Trials: Dg Icmr

Covaxin got approval for phase-III trials: DG ICMR

COVID-19 Vaccine: India’s COVAXIN gets DCGI approval for human clinical trials | Covaxin India

COVAXIN, India's First COVID-19 Vaccine Candidate, Set For Phase I, II Human Trials

NDTV

‘Don’t know how long the Covid vaccines will be effective for’: DG-ICMR

Hindustan Times

Bharat Biotech Covaxin phase III trial is approved by Subject Expert Committee with 77.8% efficacy

Covaxin phase-3 trial will begin as second trial has successful results | India | Corona Vaccine

WION

Covaxin approval row: ICMR chief says Indian rules allow restricted nod without efficacy data

The Economic Times

COVID-19 Crisis: Phase-II Human Trials For Bharat Biotech's COVAXIN Vaccine To Commence In September

Major Breakthrough In COVID-19 Treatment, Bharat Biotech's COVAXIN Vaccine Gets Nod For Human Trials

India’s 'First' Indigenous COVID-19 Vaccine COVAXIN Gets Approval For Human Clinical Trial

CRUX

ICMR, SII complete enrolment of phase 3 clinical trials for Covishield

India's Covid vaccine candidates progressing well: ICMR

Human Trials of COVAXIN: All you need to know

3 Covid-19 vaccine candidates are ahead in India: ICMR chief

Covaxin shows 77.8% efficacy in phase 3 trial data: All you need to know | Covid

Hindustan Times

Covaxin 77.8% Effective In Phase 3 Trial Data: Sources

NDTV

DCGI approves India's first Covid 19 vaccine for human trials

Channel IAM-English

Oxford vaccine's late stage trials to start in a week in India, says ICMR | Oxford Covid Vaccine

The Indian Express

Coronavirus Vaccine News | DCGI Approves Phase 2 And 3 Trials Of Covaxin Of 2-18 Year-Old

Crucial WHO Meeting On Bharat Biotech's Covaxin Approval Concludes | Breaking News